---
schema_version: "secwatch.filing_event.v1"
accession: "0001651308-24-000123"
form_type: "8-K"
ticker: "ONC"
cik: "0001651308"
company_name: "BeOne Medicines Ltd."
filed_at: "2024-09-30T23:59:59+00:00"
generated_at: "2026-05-31T00:45:25.290862+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "low"
source: SEC EDGAR
---

# BeiGene updates risk factors due to SEC comment letter on China operations

## Summary
- SEC staff requested restoration of certain risk factor language related to China operations from 2022 10-K.
- Updated risk factors filed as Exhibit 99.1, restating those in 2023 10-K and subsequent 10-Qs.
- Specific content of updated risk factors not detailed in available filing text.

## SEC filing metadata
- accession: 0001651308-24-000123
- form_type: 8-K
- ticker: ONC
- cik: 0001651308
- company_name: BeOne Medicines Ltd.
- filed_at: 2024-09-30T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: low
- sec_items: 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000123/0001651308-24-000123-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1651308/000165130824000123/bgne-20240930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001651308-24-000123
- JSON: https://secwatch.observer/filing/0001651308-24-000123.json
- Plain text: https://secwatch.observer/filing/0001651308-24-000123.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.